Bone marrow-derived mesenchymal stem cells and the tumor microenvironment.

Area of Science:

• Oncology
• Stem Cell Biology
• Cancer Microenvironment Research

Background:

• Mesenchymal stem cells (MSC) are multipotent stromal cells with a complex role in cancer.
• Their interaction with tumor cells is dual, influencing tumor progression and the tumor microenvironment.
• Bone marrow-derived MSC are particularly implicated in promoting osteolysis, tumor growth, survival, and drug resistance.

Purpose of the Study:

• To review the biology and role of MSC in cancer progression.
• To elucidate the complex interactions between MSC and tumor cells.
• To highlight the potential for novel therapeutic strategies targeting MSC in cancer.

Main Methods:

• Literature review focusing on mesenchymal stem cells and cancer.
• Analysis of the dual role of MSC in primary and metastatic tumors.
• Examination of MSC interactions within the bone marrow microenvironment.

Main Results:

• MSC can differentiate into tumor-associated fibroblasts, influencing tumor cell survival and angiogenesis.
• MSC exhibit immunomodulatory functions within the tumor microenvironment.
• Tumor cells in the bone marrow attract MSC, fostering an environment conducive to tumor growth and drug resistance.

Conclusions:

• The role of MSC in cancer is complex and context-dependent, with both pro- and anti-tumorigenic effects reported.
• Understanding MSC-tumor cell interactions is crucial for developing targeted cancer therapies.
• Further investigation into these interactions, particularly with bone marrow-derived MSC, holds promise for novel therapeutic approaches, as seen in myeloma treatment.